HomeWAVE • CVE
add
Waverley Pharma Inc
Previous close
$0.010
Day range
$0.020 - $0.020
Year range
$0.010 - $0.035
Market cap
810.00K CAD
Avg Volume
5.24K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 22.42K | -76.67% |
Operating expense | 243.47K | -20.43% |
Net income | -272.91K | 11.95% |
Net profit margin | -1.22K | -277.39% |
Earnings per share | — | — |
EBITDA | -227.81K | -13.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 239.30K | 658.16% |
Total assets | 1.78M | -12.88% |
Total liabilities | 3.80M | 105.05% |
Total equity | -2.02M | — |
Shares outstanding | 54.00M | — |
Price to book | -0.25 | — |
Return on assets | -45.58% | — |
Return on capital | -98.10% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -272.91K | 11.95% |
Cash from operations | 46.72K | 117.44% |
Cash from investing | -611.65K | — |
Cash from financing | 749.07K | 197.69% |
Net change in cash | 184.14K | 1,230.70% |
Free cash flow | 122.08K | 170.70% |
About
Founded
2014
Headquarters
Website
